glutamine has been researched along with Cognition Disorders in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.45) | 18.7374 |
1990's | 2 (6.90) | 18.2507 |
2000's | 11 (37.93) | 29.6817 |
2010's | 15 (51.72) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alt, J; Chao, W; Dash, RP; Hadas, E; Kamiya, A; Kelschenbach, J; Kim, BH; Lovell, LE; Manning, AA; Nedelcovych, MT; Prchalová, E; Rais, R; Slusher, BS; Thomas, AG; Volsky, DJ; Wu, Y; Zhu, X | 1 |
Kawada, K; Kuramoto, N; Yoneda, Y | 1 |
Ahluwalia, V; Bajaj, JS; Bouneva, I; Fuchs, M; Gilles, H; Heuman, DM; Kraft, KA; Luketic, V; Puri, P; Sanyal, AJ; Sterling, RK; Stravitz, RT; Thacker, L; Wade, JB | 1 |
Bolo, NR; Francis, AN; Keshavan, MS; Mathew, IT; Sanghavi, K; Stanley, JA; Tandon, N | 1 |
Long, JD; Paulsen, JS; Smith, MM | 1 |
Caliskan, G; Chronowska, E; Dugladze, T; Eller, J; Gloveli, T; Haas, CA; Häussler, U; Heinemann, U; Jüttner, R; Kowalczyk, S; Kulik, A; Maggio, N; Meier, JC; Rathjen, FG; Rechavi, G; Schwarz, G; Semtner, M; Smolinsky, B; Winkelmann, A | 1 |
Fan, Y; Gao, Y; Liu, X; Sun, D; Wu, G; Yan, Y; Zeng, J; Zhang, J | 1 |
Andrés, E; Fayed, N; Garcia-Campayo, J; Modrego, PJ; Viguera, L | 1 |
Brennan, BP; Hudson, JI; Janes, AC; Jensen, JE; Kanayama, G; Kaufman, MJ; Kerrigan, AR; Pope, HG | 1 |
Danese, S; Gupta, RK; Haris, M; Marincola, FM; Rangan, M; Rutella, S; Saraswat, VA; Thomas, MA; Wang, E; Yadav, SK | 1 |
Enns, GM | 1 |
Guerrant, RL; Lima, AA; Moore, SR; Oriá, MO; Oriá, RB | 1 |
Doezema, D; Elgie, R; Gasparovic, C; Ling, J; Mannell, M; Mayer, AR; Phillips, J; Yeo, R | 1 |
Frölich, L; Kratzsch, T; Lais, C; Lanfermann, H; Maurer, K; Pantel, J; Pilatus, U; Rochmont, Adu M; Zanella, FE | 1 |
Bolo, N; Jacobson, AM; Kim, JE; Lyoo, IK; Musen, G; Renshaw, PF; Ryan, CM; Simonson, DC; Weinger, K; Yoon, SJ | 1 |
Barker, PB; Mohamed, MA; Moxley, RT; Pomper, MG; Sacktor, NC; Selnes, OA; Skolasky, RL | 1 |
Apfeldorf, W; Bustillo, JR; Caprihan, A; Chen, H; Gasparovic, C; Lauriello, J; Mullins, P; Posse, S; Qualls, C | 1 |
Gomez-Esteban, JC; Lezcano, E; Molano, A; Somme, JH; Tijero, B; Zarranz, JJ | 1 |
Borkar, VV; Gupta, RK; Pandey, CM; Rathore, RK; Srivastava, A; Thomas, MA; Yachha, SK; Yadav, A; Yadav, SK | 1 |
Ahluwalia, V; Bajaj, JS; Bouneva, I; Fuchs, M; Gilles, H; Heuman, DM; Kraft, KA; Luketic, V; Monteith, P; Noble, NA; Puri, P; Sanyal, AJ; Sterling, RK; Stravitz, RT; Wade, JB; White, MB | 1 |
Boeve, BF; Edland, SD; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; Petersen, RC; Reynolds, G; Smith, GE; Tangalos, EG | 1 |
Murck, H; Ploch, M; Schaffler, K; Seibel, K; Spitznagel, H | 1 |
Arolt, V; Heindel, W; Kersting, A; Ohrmann, P; Pedersen, A; Pfleiderer, B; Rothermundt, M; Siegmund, A; Spitzberg, K; Suslow, T | 1 |
Büchert, M; Ebert, D; Hennig, J; Olbrich, HM; Rüsch, N; Tebartz van Elst, L; Thiel, T; Valerius, G | 1 |
Goić, A; González, M; Velasco, C; Velasco, M | 1 |
Bowen, DM; Francis, PT; Procter, AW; Sims, NR | 1 |
Blüml, S; Danielsen, ER; Ross, BD | 1 |
Kondoh, T; Matsuoka, T; Nishizaki, T; Nomura, T; Shiotani, T; Watabe, S; Yoshii, M | 1 |
Lewis, DA; Lieberman, JA | 1 |
6 review(s) available for glutamine and Cognition Disorders
Article | Year |
---|---|
The role of glutamine in neurogenesis promoted by the green tea amino acid theanine in neural progenitor cells for brain health.
Topics: Amino Acid Transport System A; Animals; Brain; Cognition Disorders; Double-Blind Method; Forecasting; Glutamates; Glutamine; Hippocampus; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Transgenic; Mood Disorders; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Phosphorylation; Phytotherapy; Protein Processing, Post-Translational; Randomized Controlled Trials as Topic; Rats; Sleep Wake Disorders; Tea; TOR Serine-Threonine Kinases | 2019 |
Neurologic damage and neurocognitive dysfunction in urea cycle disorders.
Topics: Brain Edema; Carbamoyl-Phosphate Synthase I Deficiency Disease; Cognition Disorders; Glutamine; Humans; Metabolism, Inborn Errors; Mitochondria; Seizures; Urea | 2008 |
Malnutrition as an enteric infectious disease with long-term effects on child development.
Topics: Animals; Arginine; Child Nutrition Disorders; Child, Preschool; Cognition Disorders; Diarrhea; Female; Fluid Therapy; Glutamine; Growth Disorders; Humans; Infant; Infections; Intestinal Diseases; Intestinal Diseases, Parasitic; Randomized Controlled Trials as Topic | 2008 |
Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives.
Topics: Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Glutamine; Histocytochemistry; Humans; Nerve Degeneration; Neurochemistry; Neurons | 1993 |
Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy?
Topics: Animals; Astrocytes; Brain; Choline; Cognition Disorders; Disease Models, Animal; Glutamine; Hepatic Encephalopathy; Humans; Hydrogen; Inositol; Liver Cirrhosis; Liver Transplantation; Magnetic Resonance Spectroscopy; Portasystemic Shunt, Transjugular Intrahepatic; Protons | 1996 |
Catching up on schizophrenia: natural history and neurobiology.
Topics: Antipsychotic Agents; Behavioral Symptoms; Brain; Cognition Disorders; Delusions; Dopamine; Female; Glutamine; Hallucinations; Humans; Male; Neural Pathways; Psychotherapy; Schizophrenia; Synaptic Transmission | 2000 |
1 trial(s) available for glutamine and Cognition Disorders
Article | Year |
---|---|
Hypericum extract reverses S-ketamine-induced changes in auditory evoked potentials in humans - possible implications for the treatment of schizophrenia.
Topics: Adult; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Evoked Potentials, Auditory; Female; Glutamine; Humans; Hypericum; Ketamine; Male; Middle Aged; Neuropsychological Tests; Phytotherapy; Plant Extracts; Schizophrenia; Schizophrenic Psychology | 2006 |
22 other study(ies) available for glutamine and Cognition Disorders
Article | Year |
---|---|
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.
Topics: AIDS Dementia Complex; Animals; Azo Compounds; Caproates; CD11b Antigen; Cognition Disorders; Conditioning, Classical; Fear; Glutamates; Glutamine; HIV-1; Leukemia Virus, Murine; Male; Maze Learning; Memory, Short-Term; Mice; Mice, Inbred C57BL; Microglia; Norleucine; Prodrugs; Reassortant Viruses; Spatial Learning | 2019 |
Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.
Topics: Brain; Cognition; Cognition Disorders; Diuretics; Female; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Hyponatremia; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Quality of Life; Sickness Impact Profile | 2013 |
Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
Topics: Adolescent; Analysis of Variance; Aspartic Acid; Brain; Cognition Disorders; Family Health; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Protons; Schizophrenia; Young Adult | 2013 |
Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
Topics: Adult; Clinical Trials as Topic; Cognition Disorders; Disease Progression; DNA Mutational Analysis; Feasibility Studies; Female; Genetic Testing; Glutamine; Humans; Huntington Disease; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Outcome Assessment, Health Care; Prodromal Symptoms; Trinucleotide Repeat Expansion | 2013 |
Changes in neural network homeostasis trigger neuropsychiatric symptoms.
Topics: Animals; Anxiety; Brain; Cognition Disorders; Cytoplasm; Genotype; Glutamine; Glutathione Transferase; Glycine; Green Fluorescent Proteins; HEK293 Cells; Hippocampus; Homeostasis; Humans; Interneurons; Male; Memory; Mice; Mice, Transgenic; Nerve Net; Neuronal Plasticity; Oscillometry; Parvalbumins; Phenotype; Receptors, Glycine; Synaptic Transmission | 2014 |
Abnormal levels of brain metabolites may mediate cognitive impairment in stroke-free patients with cerebrovascular risk factors.
Topics: Aged; Biomarkers; Cerebrovascular Disorders; Cognition; Cognition Disorders; Cross-Sectional Studies; Executive Function; Female; Glutamic Acid; Glutamine; Hippocampus; Humans; Male; Memory, Short-Term; Mental Recall; Middle Aged; Neuropsychological Tests; Predictive Value of Tests; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Risk Factors | 2014 |
Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aspartic Acid; Case-Control Studies; Cognition Disorders; Creatine; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pain; Prospective Studies | 2014 |
Brain and cognition abnormalities in long-term anabolic-androgenic steroid users.
Topics: Adult; Amygdala; Anabolic Agents; Androgens; Brain; Case-Control Studies; Cognition Disorders; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Hypertrophy; Inositol; Magnetic Resonance Imaging; Male; Neural Pathways; Neuroimaging; Neuropsychological Tests; Proton Magnetic Resonance Spectroscopy | 2015 |
Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology.
Topics: Acute-On-Chronic Liver Failure; Adult; Aspartic Acid; Brain; Case-Control Studies; Cognition; Cognition Disorders; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Humans; Inositol; Liver; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Software; Treatment Outcome | 2015 |
Neurometabolite concentrations in gray and white matter in mild traumatic brain injury: an 1H-magnetic resonance spectroscopy study.
Topics: Adult; Affective Symptoms; Axons; Biomarkers; Body Water; Brain; Brain Injuries; Cognition Disorders; Corpus Callosum; Creatine; Diffuse Axonal Injury; Energy Metabolism; Female; Glutamic Acid; Glutamine; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Fibers, Myelinated; Phosphocreatine; Young Adult | 2009 |
Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition; Cognition Disorders; Creatine; Dementia; Disease Progression; Female; Follow-Up Studies; Glutamine; Humans; Inositol; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Memory; Middle Aged; Parietal Lobe; Prognosis; Severity of Illness Index | 2009 |
Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.
Topics: Adult; Cognition Disorders; Depression; Diabetes Mellitus, Type 1; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glycated Hemoglobin; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neuropsychological Tests; Prefrontal Cortex | 2009 |
Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.
Topics: Adult; Antiretroviral Therapy, Highly Active; Brain; Cognition Disorders; Cohort Studies; Female; Glutamic Acid; Glutamine; HIV Infections; HIV Seropositivity; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2010 |
Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.
Topics: Adult; Age Factors; Aspartic Acid; Biomarkers; Brain; Cognition Disorders; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neuropsychological Tests; Protons; Schizophrenia; Schizophrenic Psychology | 2011 |
Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1).
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Cognition Disorders; Disease Progression; Family Health; Female; Glutamine; Humans; Longitudinal Studies; Lysine; Male; Mutation; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Time Factors | 2011 |
Serial evaluation of children with ALF with advanced MRI, serum proinflammatory cytokines, thiamine, and cognition assessment.
Topics: Brain; Brain Edema; Case-Control Studies; Child; Child, Preschool; Choline; Cognition; Cognition Disorders; Cytokines; Female; Follow-Up Studies; Glutamine; Hepatic Encephalopathy; Humans; Inflammation Mediators; Interleukin-6; Liver; Liver Failure, Acute; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mammillary Bodies; Thiamine; Tumor Necrosis Factor-alpha | 2012 |
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.
Topics: Adult; Arginine; Aspartic Acid; Biomarkers; Brain; Cognition Disorders; Cross-Sectional Studies; Female; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prospective Studies | 2013 |
Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition Disorders; Creatine; Female; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; ROC Curve | 2003 |
Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Topics: Adult; Aged; Antipsychotic Agents; Aspartic Acid; Choline; Chronic Disease; Cognition Disorders; Creatine; Dominance, Cerebral; Energy Metabolism; Female; Frontal Lobe; Glutamic Acid; Glutamine; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mental Recall; Middle Aged; Neurons; Phosphocreatine; Prefrontal Cortex; Psychiatric Status Rating Scales; Reference Values; Schizophrenia; Verbal Learning | 2007 |
Neurochemical and structural correlates of executive dysfunction in schizophrenia.
Topics: Adult; Amygdala; Aspartic Acid; Atrophy; Brain; Cognition Disorders; Dominance, Cerebral; Female; Glutamic Acid; Glutamine; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neuropsychological Tests; Prefrontal Cortex; Problem Solving; Schizophrenia, Paranoid | 2008 |
[Glutamine in cerebrospinal fluid in the diagnosis of altered consciousness of hepatic origin].
Topics: Adolescent; Adult; Aged; Cognition Disorders; Consciousness Disorders; Female; Glutamine; Hepatic Encephalopathy; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1984 |
Presynaptic nicotinic acetylcholine receptors as a functional target of nefiracetam in inducing a long-lasting facilitation of hippocampal neurotransmission.
Topics: Acetylcholine; Alzheimer Disease; Animals; Cognition Disorders; Electrophysiology; Glutamine; Hippocampus; Nootropic Agents; Oocytes; Protein Kinase C; Pyrrolidinones; Receptors, Nicotinic; Synaptic Transmission; Xenopus | 2000 |